William Bertrand Net Worth & Insider Trades
William Bertrand - Chief Operating Officer, Adaptimmune Therapeutics Plc
What is William Bertrand's Net Worth?
The current estimated net worth of Adaptimmune Therapeutics Plc's Chief Operating Officer, William Bertrand, is estimated to be about $340.04K . William Bertrand owns about 284,808 units of Adaptimmune Therapeutics Plc common stock. Recently at Adaptimmune Therapeutics Plc, William Bertrand has sold an estimated value of $0 worth.
What is William Bertrand's Past Insider Trading?
William Bertrand's largest purchase order was 207,000 units , worth over $143.82K on December 15, 2020. In total, William Bertrand has made about 1 transaction recently at Adaptimmune Therapeutics Plc. William Bertrand usually trades in December, with the busiest year in 2020.
William Charles Bertrand
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was William Bertrand's Salary in 2020?
As Chief Operating Officer of Adaptimmune Therapeutics Plc, William Bertrand has a total base salary of $443,456 . William Bertrand received compensation valued at about $1,551,113 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of option awards of $857,661 , other earnings, plans or compensations of $219,511 , and other compensation of $30,485 .
What is William Bertrand's' Mailing Address?
- Mailing address is One Medimmune Way Gaithersburg MD 20878 MD
Adaptimmune Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Adrian Rawcliffe | 2020 | $574,000 | $1,715,346 | $378,840 | $33,416 | $2,701,602 |
| Adrian Rawcliffe | 2019 | $500,481 | $1,427,399 | $177,251 | $49,912 | $2,155,042 |
| Adrian Rawcliffe | 2018 | $457,011 | $730,791 | $174,807 | $54,775 | $1,417,384 |
| Gavin Wood | 2020 | $337,065 | $990,268 | $166,847 | $73,731 | $1,567,911 |
| Helen Tayton-Martin | 2020 | $454,940 | $857,661 | $225,195 | $23,531 | $1,561,327 |
| Helen Tayton-Martin | 2019 | $435,949 | $766,900 | $137,324 | $30,491 | $1,370,664 |
| Helen Tayton-Martin | 2018 | $408,308 | $730,791 | $156,178 | $22,007 | $1,317,284 |
| William Bertrand | 2020 | $443,456 | $857,661 | $219,511 | $30,485 | $1,551,113 |
| William Bertrand | 2019 | $432,640 | $766,900 | $136,282 | $35,358 | $1,371,180 |
| William Bertrand | 2018 | $416,000 | $685,114 | $159,120 | $35,070 | $1,295,304 |
| John Lunger | 2020 | $400,000 | $857,661 | $198,000 | $31,802 | $1,487,463 |
| John Lunger | 2019 | $366,867 | $435,546 | $94,542 | $35,655 | $932,610 |
| John Lunger | 2018 | $316,958 | $602,909 | $92,948 | $35,07 | $1,047,885 |
| Michael Garone | 2020 | $217,000 | - | - | - | $217,000 |
| Michael Garone | 2019 | $206,500 | - | - | - | $206,500 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm
What are Adaptimmune Therapeutics Plc's Past Insider Trades?
Adaptimmune Therapeutics Plc's most recent insider trade came on January 31, 2023 by Cintia Piccina who sold 11,890 units worth $22.23K . In the last 7 years, insiders at Adaptimmune Therapeutics Plc have sold an estimated value of $40.34M and bought an estimated value of $526.78M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Adrian Rawcliffe, Chief Executive Officer, John Lunger, Chief Patient Supply Officer, and William Charles Bertrand, Chief Operating Officer .
Adaptimmune Therapeutics PLC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||